<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3411</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2021.SP134</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Synthesis, Biological Properties and Comparative Molecular Docking Evaluation Studies of 1,3 and 1,4 Bis-Thiourea Derivatives as Potential Antimicrobial Resistant Agents&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zullkiplee</surname><given-names>Wan Sharifatun Handayani Wan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rasin</surname><given-names>Ferlicia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Halim</surname><given-names>Ainaa Nadiah Abd</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mortadza</surname><given-names>Nur Arif</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ramli</surname><given-names>Noratika</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hani</surname><given-names>Nur Izma</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ngaini</surname><given-names>Zainab</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>23</day><month>02</month><year>2021</year></pub-date><volume>en</volume><issue>es</issue><fpage>23</fpage><lpage>30</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: Thiourea is one of the promising class of compounds that possess various pharmacological activity including antibacterial properties. Objective: The rise of microbial resistant drugs has triggered an alarming response among researchers to developed new drugs with effective biological properties. The position of substituents and active pharmacophores play an important role in designing a lead compound with effective biological properties. Methods: In this study, two series of 1,3-bis-thiourea derivatives (3a-l) and 1,4 bis-thiourea derivatives (4a-l) were synthesised from the reaction of isophthaloyl diisothiocyanate intermediates with halogenated amines. Results: The comparative studies of antibacterial properties of 3a-l and 4a-l against the growth of E. coli showed the minimum inhibition of 3g (7mm inhibition) and 4g (18mm inhibition) compared to standard drug ampicillin (16mm inhibition). Molecular docking evaluation against E. coli DNA gyrase B showed strong binding interaction of 4g with binding affinity -6.7 kcal/mol and more hydrogen bond compared to 3g with binding affinity -6.4 kcal/mol). Conclusion: The study is significant in drug design in particular for the development of potential drugs with antimicrobial resistant properties.&#13;
</p></abstract><kwd-group><kwd>Anilines</kwd><kwd> Carbamothioyl</kwd><kwd> Escherichia coliform</kwd><kwd> Halogens</kwd></kwd-group></article-meta></front></article>
